Valuation: Phaarmasia Limited

Market Cap 513M 5.39M 4.68M 4.37M 4.01M 7.56M 7.7M 51.53M 20.18M 256M 20.23M 19.78M 844M P/E 2024
-38.3x
P/E 2025 -12.6x
Enterprise Value 511M 5.37M 4.66M 4.35M 4M 7.54M 7.67M 51.34M 20.11M 255M 20.16M 19.71M 841M EV / Sales 2024
0.64x
EV / Sales 2025 0.81x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-1.07%
1 week-1.90%
Current month-1.07%
1 month-11.19%
3 months-10.66%
6 months-11.41%
Current year-22.21%
1 week 80.75
Extreme 80.75
97.65
1 month 80.75
Extreme 80.75
103.67
Current year 69
Extreme 69
131.75
1 year 26
Extreme 26
131.75
3 years 23.25
Extreme 23.25
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 12/02/2016
Compliance Officer - 03/01/2020
Director TitleAgeSince
Chairman 71 14/10/2010
Director/Board Member 55 09/12/2012
Director/Board Member 63 19/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%-1.90%+181.36%+265.26% 6.34M
-2.39%-6.36%+47.10%+149.66% 1,024B
-0.76%-4.34%+52.04%+49.09% 618B
-2.33%-4.60%+25.55%+64.44% 443B
+0.68%-1.14%+38.47%+33.36% 349B
-1.66%-3.13%+32.18%+39.79% 297B
-8.96%-10.77%+3.57%+5.50% 264B
-1.37%-7.41%-2.10%-43.67% 209B
-1.63%+0.69%+27.62%+64.23% 208B
+0.72%+0.48%+15.88%+73.64% 162B
Average -1.49%-2.75%+42.17%+70.13% 357.38B
Weighted average by Cap. -0.98%-3.82%+34.56%+70.87%

Financials

2024 2025
Net sales 306M 3.21M 2.79M 2.6M 2.39M 4.51M 4.59M 30.71M 12.03M 153M 12.06M 11.79M 503M 244M 2.56M 2.22M 2.07M 1.9M 3.59M 3.65M 24.46M 9.58M 122M 9.6M 9.39M 401M
Net income -5.18M -54.37K -47.25K -44.11K -40.5K -76.36K -77.69K -520K -204K -2.58M -204K -200K -8.52M -15.89M -167K -145K -135K -124K -234K -238K -1.6M -625K -7.93M -626K -612K -26.14M
Net Debt -3.43M -36.01K -31.29K -29.22K -26.82K -50.57K -51.45K -344K -135K -1.71M -135K -132K -5.65M -1.94M -20.32K -17.66K -16.49K -15.14K -28.54K -29.04K -194K -76.15K -966K -76.33K -74.64K -3.19M
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
36
Date Price Change Volume
03/08/26 ₹87.70 -1.07% 193
31/07/26 ₹88.65 +4.29% 412
30/07/26 ₹85.00 -4.76% 186
29/07/26 ₹89.25 -4.03% 1,501
28/07/26 ₹93.00 -0.93% 690
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock